(Q70201443)
Statements
Oral administration of idarubicin as first line cytostatic therapy in patients with metastasized breast cancer and favourable prognosis. A trial of the phase II study group of the Association for Medical Oncology of the German Cancer Society (English)
K Possinger
H Wagner
P Worst
W Queisser
K Bremer
K Rieche
M Klee
M Westerhausen
R Donhuijsen-Ant